医学
内科学
不利影响
倾向得分匹配
胃肠病学
化疗
回顾性队列研究
疾病
肿瘤科
外科
作者
LL Wang,Y-X Xie,Yanhong Liu
出处
期刊:PubMed
日期:2024-01-01
卷期号:28 (2): 659-667
标识
DOI:10.26355/eurrev_202401_35062
摘要
The aim of this study was to investigate the clinical efficacy and associated adverse reactions of Programmed Death Receptor-1 (PD-1)/PD-L1 inhibitors in the management of patients with advanced esophageal squamous cell carcinoma (ESCC).
科研通智能强力驱动
Strongly Powered by AbleSci AI